HSP90抑制剂的最新发展:更新的专利审查 (2020年至今)
Jianfeng Liu1,2, Huangliang Shu1,2, Qinxin Xia1,2
1State Key Laboratory of Natural Medicines and Jiangsu Key Laboratory of Drug Design and Optimization, China Pharmaceutical University, Nanjing, China.
Expert opinion on therapeutic patents
|March 5, 2024
概括
热冲击蛋白90 (HSP90) 抑制剂对于治疗癌症等疾病至关重要. 最近的进展集中在新的药物设计上,以提高HSP90抑制剂的疗效和安全性,用于更广泛的治疗应用.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 药物发现 药物发现 药物发现
背景情况:
- 热冲击蛋白90 (HSP90) 是一种涉及癌症,炎症,神经退行和感染的分子伴侣.
- 在疾病发病过程中HSP90的作用使其成为治疗干预的重要目标.
研究的目的:
- 从2020年至2023年审查最近关于HSP90抑制剂的专利.
- 分析新兴HSP90抑制剂的结构属性,药理性质和临床潜力.
主要方法:
- 来自SciFinder (2020-2023) 的专利文献综述.
- 对HSP90抑制剂的结构特征,药物特性和治疗应用的分析.
主要成果:
- ATP结合口袋抑制剂仍然占主导地位,其中一种已经获得批准.
- 新兴的策略包括C端向,异形选择性抑制和双功能分子.
- 这些新设计旨在提高HSP90抑制剂的疗效和安全性.
结论:
- HSP90抑制剂正在随着各种药物类型和应用而演变.
- 先进的HSP90抑制剂策略显示出改善治疗各种疾病的前景.
- HSP90抑制剂代表了复杂疾病的治疗选择的发展.
更多相关视频
09:39Exploring Biomolecular Interaction Between the Molecular Chaperone Hsp90 and Its Client Protein Kinase Cdc37 using Field-Effect Biosensing Technology
Published on: March 31, 2022
3.3K
06:51Studies of Chaperone-Cochaperone Interactions using Homogenous Bead-Based Assay
Published on: July 21, 2021
2.8K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Phosphoinositides and PIPs
8.5K
Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
8.5K
Covalently Linked Protein Regulators
6.8K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.8K
